Jw Pharmaceutical

This study tests whether a new combination of diabetes drugs can help people with type 2 diabetes achieve more stable blood sugar levels. About 178 adults whose blood sugar is not well controlled with metformin and an SGLT-2 inhibitor will receive the study treatment for 12 weeks…

This study tests a new medication, KLH-2109, to see if it reduces heavy menstrual bleeding in people with uterine fibroids (non-cancerous growths in the uterus). About 254 participants will take either the new drug or a standard treatment pill. Researchers will track bleeding lev…

This study is testing a fixed-dose combination of two cholesterol-lowering drugs (Pitavastatin and Ezetimibe) in 10,000 adults with high cholesterol and metabolic syndrome. The goal is to see how much LDL (bad) cholesterol drops after 24 and 48 weeks of treatment in real-world se…

This study tests whether taking two medications together (JW0104 and C2402) is safe and effective for people with both high blood pressure and high cholesterol. About 162 adults will receive either the combo or a placebo. The goal is to see if the combo lowers blood pressure and …

This early-stage study tests whether a new topical drug called JW0061 is safe for healthy adults. About 104 Korean and Caucasian volunteers will receive either the drug or a placebo cream. The goal is to check for side effects and how the body processes the drug, not to treat any…